微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -0.86% | -121.61% | 64.61% | 37/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | -2.43% | -358.51% | 27.46% | 42/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | -3.35% | -247.58% | -181.71% | 47/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 4.1% | -69.1% | 3.02% | 28/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 3.98% | -53.12% | 323.4% | 30/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 0.94% | -80.04% | -58.59% | 35/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 2.27% | 30.46% | -82.89% | 18/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 13.27% | 48.1% | 56.3% | 17/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 8.49% | 87% | 80.25% | 23/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 4.71% | 76.4% | 170.69% | 23/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 1.74% | -43.51% | -80.58% | 23/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 8.96% | -68.58% | 97.36% | 30/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 4.54% | -65.37% | 70.04% | 26/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 2.67% | -69.76% | -13.31% | 31/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 3.08% | 35.09% | -89.2% | 14/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 28.52% | 28.01% | 117.54% | 6/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 13.11% | 16.43% | 48.47% | 12/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 8.83% | 101.6% | 287.28% | 8/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 2.28% | 24.59% | -89.77% | 7/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 22.28% | 48.63% | 97.87% | 11/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 11.26% | 13.97% | 157.08% | 13/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 4.38% | 62.83% | 139.34% | 14/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 1.83% | 17.31% | -87.79% | 15/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 14.99% | -15.5% | 51.72% | 16/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 9.88% | -14.09% | 267.29% | 11/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 2.69% | -14.87% | 72.44% | 17/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 1.56% | 2% | -91.21% | 13/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 17.74% | -6.83% | 54.26% | 8/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 11.5% | 2% | 263.92% | 10/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 3.16% | 2% | -83.4% | 19/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2016-12-31 | 19.04% | -11.32% | -11.32% | 12/51 | 23.06% | 南华生物 | 1666.98% | 行业排名> |
| 2015-12-31 | 21.47% | -13.25% | -13.25% | 6/51 | 22.23% | 爱尔眼科 | 5.19% | 行业排名> |